Reply to Comment on Failure of a Mexican antivenom on recovery from snakebite-related coagulopathy in French Guiana
Clin Toxicol (Phila)
.
2021 Mar;59(3):267-268.
doi: 10.1080/15563650.2020.1814317.
Epub 2020 Sep 1.
Authors
Xavier Heckmann
1
2
,
Véronique Lambert
3
,
Georges Mion
4
,
Adrien Ehrhardt
5
,
Christian Marty
2
,
Frédérique Perotti
6
,
Jean-François Carod
7
,
Anne Jolivet
8
,
David Boels
9
,
Ibrahim Lehida Andi
10
,
Sébastien Larréché
11
Affiliations
1
Emergency Department, Western Guiana Hospital, Saint-Laurent-du-Maroni, French Guiana.
2
French Red Cross, Cayenne, French Guiana.
3
Department of Obstetrics and Gynaecology, Western Guiana Hospital, Saint-Laurent-du-Maroni, French Guiana.
4
Department of Anaesthesiology, Cochin Hospital, Paris, France.
5
INRIA Lille-Nord Europe, Villeneuve-d'Ascq, France.
6
Pharmacy, Western Guiana Hospital, Saint-Laurent-du-Maroni, French Guiana.
7
Department of Medical Biology, Western Guiana Hospital, Saint-Laurent-du-Maroni, French Guiana.
8
Department of Public Health, Western Guiana Hospital, Saint-Laurent-du-Maroni, French Guiana.
9
Poison Control Center, Angers University Hospital, Angers, France.
10
Department of Anaesthesiology and Reanimation, Western Guiana Hospital, Saint-Laurent-du-Maroni, French Guiana.
11
Department of Medical Biology, Bégin Military Teaching Hospital, Saint-Mandé, France.
PMID:
32870069
DOI:
10.1080/15563650.2020.1814317
No abstract available
Publication types
Letter
Comment
MeSH terms
Antivenins / therapeutic use
Blood Coagulation Disorders* / chemically induced
Blood Coagulation Disorders* / drug therapy
French Guiana
Humans
Snake Bites* / complications
Snake Bites* / drug therapy
Substances
Antivenins